Top 10 Pre-Market Analyst Calls (ADBE, CRL, GEOY, NOKU, HUN, IVGN, LRCX, NVO, RTN, YHOO)

Investing

Published: June 24, 2008 6:43 am

Last Updated: March 26, 2020 8:22 pm

These are not all of the calls we are seeing in pre-market coverage, but these are ten of the calls impacting shares this Tuesday morning:

Adobe (NASDAQ: ADBE) raised to Overweight from Equal Weight at Morgan Stanley.
Charles River Laboratories (NYSE: CRL) downgraded to Neutral at Goldman Sachs.
GeoEye (NASDAQ: GEOY) started as Overweight at JPMorgan.
Hoku Scientific (NASDAQ: HOKU) downgraded to Neutral from Buy at Broadpoint.
Huntsman (NASDAQ: HUN) raised to Buy from Neutral at UBS.
Invitrogen (NASDAQ: IVGN) Raised to Overweight from Neutral at JPMorgan.
Lam Research (NASDAQ: LRCX) raised to Goldman Sachs Conviction Buy List from Sell at Goldman Sachs.
Novo Nordisk (NYSE: NVO) Raised to Buy from Neutral at Goldman Sachs.
Raytheon (NYSE: RTN) Raised to Overweight from Neutral at JPMorgan.
Yahoo! (NASDAQ: YHOO) Downgraded to Underweight from Market Weight at Thomas Weisel.

Elsewhere in analyst coverage, you can see the full medical & biotech calls at BioHealthInvestor.com and earlier we covered some more exclusive analyst calls in Telecom, Media & Tech as well as Credit Suisse initiating coverage on the Homebuilder sector.
Jon C. Ogg
June 24, 2008

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.